id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1981-N-0015-0039,FDA,FDA-1981-N-0015,Letter from Consumer Healthcare Products Association (CHPA) re Oral Health Care Drug Products for OTC Human Use,Other,Letter(s),2008-09-29T04:00:00Z,2008,9,2008-09-29T04:00:00Z,,2015-04-29T17:41:20Z,,0,0,0900006480702320
FDA-1981-N-0015-0038,FDA,FDA-1981-N-0015,Letter from FDA CDER to Consumer Healthcare Products Association re 1981N-0033P,Other,Letter(s),2008-08-15T04:00:00Z,2008,8,2008-08-15T04:00:00Z,,2015-04-29T17:35:34Z,,0,0,09000064806a1695
FDA-1981-N-0015-0036,FDA,FDA-1981-N-0015,Letter from FDA/CDER to the Global Oral Care Procter & Gamble Company,Other,Letter(s),2008-08-15T04:00:00Z,2008,8,2008-08-15T04:00:00Z,,2015-04-29T17:28:03Z,,0,0,09000064806a1584
FDA-1981-N-0015-0037,FDA,FDA-1981-N-0015,Letter from FDA CDER to Combe Incorporated re Stephen Pennisi,Other,Letter(s),2008-08-15T04:00:00Z,2008,8,2008-08-15T04:00:00Z,,2015-04-29T17:36:29Z,,0,0,09000064806a1623